NCT02656251

Brief Summary

The aim of the study is to compare the effect of a suspension containing chlorhexidine and alcohol and another one containing clorhexidine with no alcohol in dynamic of the subgingival biofilm formation versus a Placebo suspension. The initial subgingival biofilm formation will be evaluated by means of Plaque Free Zone (PFZ).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jul 2015

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2015

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 14, 2016

Completed
Last Updated

January 14, 2016

Status Verified

January 1, 2016

Enrollment Period

5 months

First QC Date

November 18, 2015

Last Update Submit

January 13, 2016

Conditions

Keywords

biofilmscross over trialchlorhexidine

Outcome Measures

Primary Outcomes (1)

  • Efficacy of two clorhexidine formulations to Control the Initial Subgingival Biofilm Formation assessed by the plaque free zone index.

    The presence of scores 0, 1 or 2 of the index "Plaque Free Zone" will be recorded at baseline and at each 24 hours, during a period of 96 hours (4 days).

    24hours

Study Arms (3)

0.12% Clorhexidine with alcohol

ACTIVE COMPARATOR

0.12% Clorhexidine with alcohol, 15ml every 12 hour for 4 days

Drug: 0.12% Clorhexidine with alcoholDrug: placeboDrug: 0.12% Clorhexidine without alcohol

0.12% Clorhexidine without alcohol

EXPERIMENTAL

0.12% Clorhexidine without alcohol, 15ml every 12 hour for 4 days

Drug: 0.12% Clorhexidine with alcoholDrug: placeboDrug: 0.12% Clorhexidine without alcohol

control

PLACEBO COMPARATOR

placebo 15ml every 12 hour for 4 days

Drug: 0.12% Clorhexidine with alcoholDrug: placeboDrug: 0.12% Clorhexidine without alcohol

Interventions

Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days

Also known as: Periogard, No plak
0.12% Clorhexidine with alcohol0.12% Clorhexidine without alcoholcontrol

Use of placebo every 12 hours for 04 days

0.12% Clorhexidine with alcohol0.12% Clorhexidine without alcoholcontrol

Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days

Also known as: Periogard
0.12% Clorhexidine with alcohol0.12% Clorhexidine without alcoholcontrol

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age from 18 years;
  • non-smokers;
  • have good general health;
  • present at least 20 natural teeth in the mouth, including the incisors, canines and premolars without restorations, crowns, gingival recession, anatomic defects, gingivitis e/or periodontitis.

You may not qualify if:

  • positive history of using antibiotic e/or anti-inflammatory drugs in the month previous to the initial consultation;
  • positive history of allergies at using Triclosan;
  • pregnant or lactating patients;
  • patients in use of fixed orthodontic appliance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil

Location

MeSH Terms

Conditions

Dental Plaque

Interventions

EthanolChlorhexidine

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsBiguanidesGuanidinesAmidines

Study Officials

  • Patricia Weidlich, PhD

    Federal University of Rio Grande do Sul

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

November 18, 2015

First Posted

January 14, 2016

Study Start

July 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 14, 2016

Record last verified: 2016-01

Locations